science
SAMHSA Removes Buprenorphine Provider Locator on June 8
The Substance Abuse and Mental Health Services Administration removed its national buprenorphine provider locator. Earlier actions included grant terminations and the end of support for fentanyl testing strips.
The HillAudio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.
The Substance Abuse and Mental Health Services Administration removed the national buprenorphine provider locator from its website on June 8. The free online database had helped users find addiction treatment providers. In January the agency terminated nearly $2 billion in grants for addiction treatment, reentry, recovery support and naloxone distribution.
It reversed those terminations 24 hours later after bipartisan pressure. An April Dear Colleague letter from SAMHSA ended federal support for fentanyl testing strips. The House proposed 2026 appropriations for the Department of Health and Human Services that cut Centers for Disease Control and Prevention funding by 19 percent and zeroed out more than 100 programs across HHS agencies including SAMHSA, the Health Resources and Services Administration and state and local health departments.
The final House proposal held SAMHSA funding roughly level at $7.4 billion. Roughly 196 Americans die of overdose every day. Buprenorphine cuts overdose risk roughly in half. The administration's 2026 National Drug Control Strategy prioritizes treatment access, recovery support and data infrastructure.
